13G Filing: Broadfin Capital and Corium International Inc. (CORI)

Page 9 of 10

Page 9 of 10 – SEC Filing

AGREEMENT
The undersigned agree that this Schedule 13G, Amendment No. 4, dated May 25, 2017 relating to the Common Stock of Corium International, Inc. shall be filed on behalf of the undersigned.
May 25, 2017
(Date)
BROADFIN CAPITAL, LLC
By: /s/ Kevin Kotler
(Signature)
Kevin Kotler, Managing Member
(Name/Title)
May 25, 2017
(Date)
BROADFIN HEALTHCARE
MASTER FUND, LTD.
By: /s/ Kevin Kotler
(Signature)
Kevin Kotler, Director
(Name/Title)
May 25, 2017
(Date)
By: /s/ Kevin Kotler
(Signature)
Kevin Kotler
(Name/Title)
The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative.  If the statement is signed on behalf of a person by his authorized representative other than an executive officer or general partner of the filing person, evidence of the representative’s authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference.  The name and any title of each person who signs the statement shall be typed or printed beneath his signature.
Note.  Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See s.240.13d-7 for other parties for whom copies are to be sent.
Attention.  Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001).

Follow Corium International Inc. (NASDAQ:CORI)

Page 9 of 10